Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation (nano-PFA or nsPFA) technology, today announced plans to participate in the upcoming Stifel 2026 Healthcare Conference in New York, NY. Pulse Biosciences...